GPR183 and multiple sclerosis: In summary, the work of Wanke et al. (128) supports the hypothesis that in multiple sclerosis GPR183 and 7α,25-diHC promote the redistribution of inflammatory Th17 cells from secondary lymphoid organs to sites of inflammation.